| Catalog Number | CBCL-0603 |
| Price | Online Inquiry |
| Unit Quantity | 5 x 10^6 cells / 1.0 ml |
The HEK293-Human CD19-Stable Cell Line is a stable cell line expressing human CD19.
For cell-based binding assays
CD19 is a B cell-specific surface glycoprotein expressed throughout B cell development (pro-B to mature B cells). It forms a co-receptor complex with CD21 and CD81, lowering the threshold for B cell activation by antigens. CD19 is a key target for CAR-T cell therapy in B cell malignancies (e.g., leukemia, lymphoma).
| Category | CAR-T Therapy Cell Lines |
| Cell Line Name | HEK293-Human CD19-Stable Cell Line |
| Protein Family | CD19 family |
| Gene | CD19 |
| NCBI Gene ID | 930 |
| Species | Human |
| Host Cell Line | HEK293 |
| Cell Type | Human embryonic kidney cells |
| Morphology | Epithelial |
| Growth Properties | Adherent |
| Selection Marker | Puro (10 μg/mL) |
| Recommended Medium | DMEM + 10% FBS |
| Freeze Medium | 10% DMSO + 90% FBS |
| Storage Method | Frozen in liquid nitrogen. |
| Stability | Validated for at least 10 passages |
| Mycoplasma | Negative |
| Sterility Testing | Negative |
| Shipping | Shipping in dry ice |
| Biosafety Level | BSL-1 |
| Caution | For Research Use Only |